Business

Capstan Therapeutics, a Penn spinout whose founders include Carl June, Bruce Levine, and Drew Weissman of the Perelman School of Medicine, has launched with $165 million raised to develop a new type of CAR therapy that incorporates mRNA.

In a co-authored op-ed, Ioana Marinescu of the School of Social Policy & Practice outlines the key federal measures that could enable workers to find new, higher-paying jobs.

A study from the Wharton School found that despite overall gains in gender diversity, the COVID-19 pandemic relegated many women to support functions at Fortune 100 companies.

In an op-ed, Susan Wachter of the Wharton School writes about how ongoing monetary policy has resulted in high house prices and rates of rent alongside low construction and sales activity.

Karen Lasater of the School of Nursing says that most hospitals try to subsist on thin margins of staffing, which for nurses results in worse results for patients and eroded trust in their employers.

Adam Grant of the Wharton School says that letting people work outside the office frees them from group think and micromanagement, allowing them to generate more and better ideas.

Steve Viscelli of the School of Arts & Sciences says that labor shortage claims are industry-lobbying rhetoric meant to reframe the issue as a scarcity of workers rather than a lack of decent jobs.

Kevin Werbach of the Wharton School acknowledges that there’s a lot of uncertainty and hype around the blockchain space and says that traditional firms will need people who understand it.

In an op-ed, Christopher Yoo of Penn Carey Law argues that enacting antitrust legislation in response to “techlash” would disincentivize innovation and penalize companies for being successful.